Pauls Dietrich John 4
4 · DiaMedica Therapeutics Inc. · Filed Jun 3, 2025
Insider Transaction Report
Form 4
Pauls Dietrich John
DirectorPresident & CEO
Transactions
- Award
Stock Option (right to buy)
2025-06-01+600,000→ 600,000 totalExercise: $4.11Exp: 2035-05-31→ Common Shares (600,000 underlying)
Holdings
- 68,591
Voting Common Shares, no par value per share
Footnotes (2)
- [F1]Includes 1,749 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan.
- [F2]Vests with respect to 25% of the underlying common shares on June 1, 2026 with the remaining 75% of the underlying common shares vesting quarterly over the following three years commencing on September 1, 2026.